title: Protein pharmacophore selection using hydration-site analysis.
abstract: Virtual screening using pharmacophore models is an efficient method to identify potential lead compounds for target proteins. Pharmacophore models based on protein structures are advantageous because a priori knowledge of active ligands is not required and the models are not biased by the chemical space of previously identified actives. However, in order to capture most potential interactions between all potentially binding ligands and the protein, the size of the pharmacophore model, i.e. number of pharmacophore elements, is typically quite large and therefore reduces the efficiency of pharmacophore based screening. We have developed a new method to select important pharmacophore elements using hydration-site information. The basic premise is that ligand functional groups that replace water molecules in the apo protein contribute strongly to the overall binding affinity of the ligand, due to the additional free energy gained from releasing the water molecule into the bulk solvent. We computed the free energy of water released from the binding site for each hydration site using thermodynamic analysis of molecular dynamics (MD) simulations. Pharmacophores which are colocalized with hydration sites with estimated favorable contributions to the free energy of binding are selected to generate a reduced pharmacophore model. We constructed reduced pharmacophore models for three protein systems and demonstrated good enrichment quality combined with high efficiency. The reduction in pharmacophore model size reduces the required screening time by a factor of 200-500 compared to using all protein pharmacophore elements. We also describe a training process using a small set of known actives to reliably select the optimal set of criteria for pharmacophore selection for each protein system.
authors.affiliation: Department of Medicinal Chemistry and Molecular Pharmacology, College of Pharmacy, Purdue University , 575 Stadium Mall Drive, West Lafayette, Indiana 47906, United States.
authors.forename: Bingjie
authors.initials: B
authors.lastname: Hu
authors.forename: Markus A
authors.initials: MA
authors.lastname: Lill
mesh_terms: D000465:Algorithms; D020134:Catalytic Domain; D062313:Databases, Pharmaceutical; D015951:Factor Xa / Q000737:chemistry*; D065427:Factor Xa Inhibitors; D016333:HIV Protease / Q000737:chemistry*; D015497:HIV-1 / Q000737:chemistry / Q000201:enzymology; D057166:High-Throughput Screening Assays; D006801:Humans; D006860:Hydrogen Bonding; D057927:Hydrophobic and Hydrophilic Interactions; D008024:Ligands; D062105:Molecular Docking Simulation; D045363:Pneumocystis carinii / Q000737:chemistry / Q000201:enzymology; D011485:Protein Binding; D011487:Protein Conformation; D054852:Small Molecule Libraries / Q000737:chemistry*; D055672:Static Electricity; D013329:Structure-Activity Relationship; D013762:Tetrahydrofolate Dehydrogenase / Q000737:chemistry*; D013816:Thermodynamics; D014867:Water / Q000737:chemistry*
chemical_list: D065427:Factor Xa Inhibitors; D008024:Ligands; D054852:Small Molecule Libraries; D014867:Water; D013762:Tetrahydrofolate Dehydrogenase; D015951:Factor Xa; D016333:HIV Protease